SOPHARMA (SPH): Issued refusal by the Registry Agency on the transformation through merger between Sopharma AD and Unipharm AD - raport 18
Raport ESPI
UNI - EN REPORT No
18
/
2018
UNI - EN REPORT No18/2018
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on April 30, 2018, the Registry Agency issued a refusal № 20180411164207 of the declared transformation of Unipharm AD into Sopharma AD under the Transformation Agreement of September, 14 2017 and the Additional Agreement of November, 8 2017.
The companies are considering to launch a new transformation procedure as soon as possible.
